Overview

Bioequivalence Study of 20 mg Omeprazole Capsules in Indonesia Healthy Subject

Status:
Completed
Trial end date:
2021-02-03
Target enrollment:
Participant gender:
Summary
The study was conducted to investigate whether 20 mg omeprazole capsules manufactured by PT. Dankos Farma for PT. Hexpharm Jaya is bioequivalent to its reference product, 20 mg LosecĀ® capsules manufactured by AstraZeneca AB, Sweden, imported by PT. AstraZeneca Indonesia.
Phase:
N/A
Details
Lead Sponsor:
PT Kalbe Farma Tbk
Collaborator:
PT Pharma Metric Labs
Treatments:
Omeprazole